Obesity during pregnancy can increase the risk of heart disease by causing molecular changes and altering nutrient metabolism genes in offspring for life.

TOP INSIGHT
Understanding the mechanisms involved can help develop new treatments that could help prevent later-life cardiometabolic illnesses early.
Research Using a Mouse Model
The researchers from the University of Colorado, US, used a mouse model that replicates human maternal physiology and placental nutrient transport in obese women.Female mice (n = 31) were fed a diet with a high-fat content together with a sugary drink, which is equivalent to a human regularly consuming a burger, chips and a fizzy drink (1,500 kcal). The female mice consumed this diet until they had developed obesity, putting on about 25% of their original body weight and 50 female mice were fed a controlled diet.
Mouse pups (n = 187) were studied in utero, as well as after birth at 3, 6, 9 and 24 months using imaging techniques, including echocardiography and positron emission tomography (PET) scans. Researchers have analyzed genes, proteins and mitochondria of the offspring.
The changes in offspring cardiac metabolism strongly depended on sex. The expression of 841 genes were altered in the hearts of female fetuses and 764 genes were altered in male fetuses, but less than 10% of genes were commonly altered in both sexes.
Interestingly,
although both male and female offspring from mothers with obesity had impaired cardiac function, there were differences in the progression between sexes;
males were impaired from the start, whereas females’ cardiac function got progressively worse with age.Lead author, Dr. Owen Vaughan, University of Colorado, US said: “Our research indicates a mechanism linking maternal obesity with cardiometabolic illness in the next generation. This is important because
obesity is increasing rapidly in the human population and affects almost one-third of women of childbearing age.
By improving our understanding of the mechanisms involved, this research paves the way for treatments that could be used in early life to prevent later-life cardiometabolic illnesses, which are costly for health services and affect many people’s quality of life. For example, we could offer more tailored advice on nutrition to mothers or children based on their body mass index or sex, or develop new drugs that target metabolism in the heart of the fetus.”Source-Eurekalert
MEDINDIA




Email










